<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink">        <front>        <journal-meta>            <journal-id journal-id-type="nlm-ta">elife</journal-id>            <journal-id journal-id-type="publisher-id">eLife</journal-id>            <journal-title-group>                <journal-title>eLife</journal-title>            </journal-title-group>            <issn publication-format="electronic">2050-084X</issn>            <publisher>                <publisher-name>eLife Sciences Publications, Ltd</publisher-name>            </publisher>        </journal-meta>        <article-meta>            <article-id pub-id-type="publisher-id">69798</article-id>            <article-id pub-id-type="doi">10.7554/eLife.69798</article-id>            <article-categories>                <subj-group subj-group-type="display-channel">                    <subject>Research Article</subject>                </subj-group>                <subj-group subj-group-type="heading">                    <subject>Epidemiology and Global Health</subject>                </subj-group>                <subj-group subj-group-type="heading">                    <subject>Microbiology and Infectious Disease</subject>                </subj-group>            </article-categories>            <title-group>                <article-title>The repurposing of Tebipenem pivoxil as alternative therapy for                    severe gastrointestinal infections caused by extensively drug resistant                        <italic>Shigella</italic> spp.</article-title>            </title-group>            <contrib-group>                <contrib contrib-type="author" corresp="yes" id="author-237039">                    <name>                        <surname>Fernández Alvaro</surname>                        <given-names>Elena</given-names>                    </name>                    <xref ref-type="aff" rid="aff1">1</xref>                    <xref ref-type="corresp" rid="cor1">*</xref>                    <xref ref-type="fn" rid="conf2"/>                </contrib>                <contrib contrib-type="author" id="author-237040">                    <name>                        <surname>Voong Vinh</surname>                        <given-names>Phat</given-names>                    </name>                    <xref ref-type="aff" rid="aff2">2</xref>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <contrib contrib-type="author" id="author-237041">                    <name>                        <surname>de Cozar</surname>                        <given-names>Cristina</given-names>                    </name>                    <xref ref-type="aff" rid="aff1">1</xref>                    <xref ref-type="fn" rid="conf3"/>                </contrib>                <contrib contrib-type="author" id="author-268628">                    <name>                        <surname>Wille</surname>                        <given-names>David</given-names>                    </name>                    <xref ref-type="aff" rid="aff1">1</xref>                    <xref ref-type="fn" rid="conf4"/>                </contrib>                <contrib contrib-type="author" id="author-237042">                    <name>                        <surname>Urones</surname>                        <given-names>Beatriz</given-names>                    </name>                    <xref ref-type="aff" rid="aff1">1</xref>                    <xref ref-type="fn" rid="conf5"/>                </contrib>                <contrib contrib-type="author" id="author-237043">                    <name>                        <surname>Cortés</surname>                        <given-names>Alvaro</given-names>                    </name>                    <xref ref-type="aff" rid="aff1">1</xref>                    <xref ref-type="fn" rid="conf6"/>                </contrib>                <contrib contrib-type="author" id="author-237044">                    <name>                        <surname>Price</surname>                        <given-names>Alan</given-names>                    </name>                    <xref ref-type="aff" rid="aff1">1</xref>                    <xref ref-type="fn" rid="conf7"/>                </contrib>                <contrib contrib-type="author" id="author-237045">                    <name>                        <surname>Tran Do Hoang</surname>                        <given-names>Nhu</given-names>                    </name>                    <xref ref-type="aff" rid="aff2">2</xref>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <contrib contrib-type="author" id="author-13532">                    <name>                        <surname>Ha Thanh</surname>                        <given-names>Tuyen</given-names>                    </name>                    <xref ref-type="aff" rid="aff2">2</xref>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <contrib contrib-type="author" id="author-237058">                    <name>                        <surname>McCloskey</surname>                        <given-names>Molly</given-names>                    </name>                    <xref ref-type="aff" rid="aff3">3</xref>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <contrib contrib-type="author" id="author-237059">                    <name>                        <surname>Shaheen</surname>                        <given-names>Shareef</given-names>                    </name>                    <xref ref-type="aff" rid="aff3">3</xref>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <contrib contrib-type="author" id="author-237060">                    <name>                        <surname>Dayao</surname>                        <given-names>Denise</given-names>                    </name>                    <xref ref-type="aff" rid="aff4">4</xref>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <contrib contrib-type="author" id="author-237061">                    <name>                        <surname>de Mercado</surname>                        <given-names>Jaime</given-names>                    </name>                    <xref ref-type="aff" rid="aff1">1</xref>                    <xref ref-type="fn" rid="conf8"/>                </contrib>                <contrib contrib-type="author" id="author-268629">                    <name>                        <surname>Castañeda</surname>                        <given-names>Pablo</given-names>                    </name>                    <xref ref-type="aff" rid="aff1">1</xref>                    <xref ref-type="fn" rid="conf9"/>                </contrib>                <contrib contrib-type="author" id="author-237062">                    <name>                        <surname>García-Perez</surname>                        <given-names>Adolfo</given-names>                    </name>                    <xref ref-type="aff" rid="aff1">1</xref>                    <xref ref-type="fn" rid="conf10"/>                </contrib>                <contrib contrib-type="author" id="author-237063">                    <name>                        <surname>Singa</surname>                        <given-names>Benson</given-names>                    </name>                    <xref ref-type="aff" rid="aff5">5</xref>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <contrib contrib-type="author" id="author-237064">                    <name>                        <surname>Pavlinac</surname>                        <given-names>Patricia</given-names>                    </name>                    <xref ref-type="aff" rid="aff6">6</xref>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <contrib contrib-type="author" id="author-237065">                    <name>                        <surname>Walson</surname>                        <given-names>Judd</given-names>                    </name>                    <xref ref-type="aff" rid="aff3">3</xref>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <contrib contrib-type="author" id="author-237070">                    <name>                        <surname>Martínez-Martínez</surname>                        <given-names>Maria Santos</given-names>                    </name>                    <xref ref-type="aff" rid="aff1">1</xref>                    <xref ref-type="fn" rid="conf11"/>                </contrib>                <contrib contrib-type="author" id="author-237067">                    <name>                        <surname>Arnold</surname>                        <given-names>Samuel LM</given-names>                    </name>                    <xref ref-type="aff" rid="aff3">3</xref>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <contrib contrib-type="author" id="author-237068">                    <name>                        <surname>Saul</surname>                        <given-names>Tzipori</given-names>                    </name>                    <xref ref-type="aff" rid="aff4">4</xref>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <contrib contrib-type="author" id="author-237069">                    <name>                        <surname>Ballell</surname>                        <given-names>Lluis</given-names>                    </name>                    <xref ref-type="aff" rid="aff1">1</xref>                    <xref ref-type="other" rid="par-2"/>                    <xref ref-type="fn" rid="conf12"/>                </contrib>                <contrib contrib-type="author" corresp="yes" id="author-193679">                    <name>                        <surname>Baker</surname>                        <given-names>Stephen</given-names>                    </name>                    <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1308-5755</contrib-id>                    <xref ref-type="aff" rid="aff7">7</xref>                    <xref ref-type="corresp" rid="cor2">*</xref>                    <xref ref-type="other" rid="par-1"/>                    <xref ref-type="other" rid="par-3"/>                    <xref ref-type="fn" rid="conf1"/>                </contrib>                <aff id="aff1"><institution>GSK Global Health</institution>,                            <addr-line><named-content content-type="city">Madrid</named-content></addr-line>, <country>Spain</country></aff>                <aff id="aff2"><institution content-type="dept">The Hospital for Tropical Diseases,                        Wellcome Trust Major Overseas Programme</institution>, <institution>Oxford                        University Clinical Research Unit</institution>, <addr-line><named-content content-type="city">Ho Chi Minh City</named-content></addr-line>,                        <country>Viet Nam</country></aff>                <aff id="aff3"><institution content-type="dept">Division of Allergy and Infectious                        Disease, Center for Emerging and Re-emerging Infectious                        Diseases</institution>, <institution>University of Washington School of                        Medicine</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United                    States</country></aff>                <aff id="aff4"><institution content-type="dept">Department of Infectious Disease and                        Global Health</institution>, <institution>Tufts University</institution>,                            <addr-line><named-content content-type="city">North                            Grafton</named-content></addr-line>, <country>United                    States</country></aff>                <aff id="aff5"><institution>Kenya Medical Research Institute</institution>,                            <addr-line><named-content content-type="city">Nairobi</named-content></addr-line>, <country>Kenya</country></aff>                <aff id="aff6"><institution content-type="dept">Department of Global                        Health</institution>, <institution>University of Washington</institution>,                            <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff>                <aff id="aff7"><institution content-type="dept">Department of                    Medicine</institution>, <institution>University of Cambridge</institution>,                            <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United                    Kingdom</country></aff>            </contrib-group>            <contrib-group content-type="section">                <contrib contrib-type="editor" id="author-150133">                    <name>                        <surname>Zambrano</surname>                        <given-names>María Mercedes</given-names>                    </name>                    <role>Reviewing editor</role>                    <aff><institution>CorpoGen</institution>, <country>Colombia</country></aff>                </contrib>            </contrib-group>            <author-notes>                <corresp id="cor1"><label>*</label>For correspondence:                        <email>elena.a.fernandez-alvaro@gsk.com</email> (EF);</corresp>                <corresp id="cor2"><label>*</label>For correspondence:                        <email>sgb47@medschl.cam.ac.uk</email> (SB);</corresp>            </author-notes>            <pub-date date-type="pub" publication-format="electronic">                <day>15</day>                <month>03</month>                <year>2022</year>            </pub-date>            <volume>11</volume>            <elocation-id>e69798</elocation-id>            <history><date date-type="received">                    <day>27</day>                    <month>04</month>                    <year>2021</year>                </date><date date-type="accepted">                    <day>09</day>                    <month>03</month>                    <year>2022</year>                </date></history>            <permissions>                <copyright-statement>© 2022, Fernández Alvaro et al</copyright-statement>                <copyright-year>2022</copyright-year>                <copyright-holder>Fernández Alvaro et al</copyright-holder>                <license xlink:href="http://creativecommons.org/licenses/by/4.0/">                    <license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative                            Commons Attribution License</ext-link> permitting unrestricted use and                        redistribution provided that the original author and source are                        credited.</license-p>                </license>            </permissions>            <self-uri content-type="pdf" xlink:href="elife-69798-v1.pdf"/><abstract>                <p><bold>Background:</bold> Diarrhoea remains one of the leading causes of childhood                    mortality globally. Recent epidemiological studies conducted in low-middle                    income countries (LMICs) identified <italic>Shigella</italic> spp. as the first                    and second most predominant agent of dysentery and moderate diarrhoea,                    respectively. Antimicrobial therapy is often necessary for                        <italic>Shigella</italic> infections; however, we are reaching a crisis                    point with efficacious antimicrobials. The rapid emergence of resistance against                    existing antimicrobials in <italic>Shigella</italic> spp. poses a serious global                    health problem.</p>                <p><bold>Methods:</bold> Aiming to identify alternative antimicrobial chemicals with                    activity against antimicrobial resistant <italic>Shigella</italic>, we initiated                    a collaborative academia-industry drug discovery project, applying high                    throughput phenotypic screening across broad chemical diversity and followed a                    lead compound through <italic>in vitro</italic> and <italic>in vivo</italic>                    characterisation.</p>                <p><bold>Results:</bold> We identified several known antimicrobial compound classes                    with antibacterial activity against <italic>Shigella.</italic> These compounds                    included the oral carbapenem Tebipenem, which was found to be highly potent                    against broadly susceptible <italic>Shigella</italic> and contemporary MDR                    variants for which we perform detailed pre-clinical testing. Additional                        <italic>in vitro</italic> screening demonstrated that Tebipenem had activity                    against a wide range of other non-<italic>Shigella</italic> enteric bacteria.                    Cognisant of the risk for the development of resistance against monotherapy, we                    identified synergistic behaviour of two different drug combinations                    incorporating Tebipenem. We found the orally bioavailable prodrug (Tebipenem                    pivoxil) had ideal pharmacokinetic properties for treating enteric pathogens and                    was effective in clearing the gut of infecting organisms when administered to                        <italic>Shigella</italic>-infected mice and gnotobiotic piglets.</p>                <p><bold>Conclusions:</bold> Our data highlight the emerging antimicrobial                    resistance crisis and shows that Tebipenem pivoxil (licenced for paediatric                    respiratory tract infections in Japan) should be accelerated into human trials                    and could be repurposed as an effective treatment for severe diarrhoea caused by                    MDR <italic>Shigella</italic> and other enteric pathogens in LMICs.</p>                <p><bold>Funding:</bold> Tres Cantos Open Lab Foundation (projects TC239 and TC246),                    the Bill and Melinda Gates Foundation (grant OPP1172483) and Wellcome                    (215515/Z/19/Z).</p>            </abstract>            <kwd-group kwd-group-type="research-organism">                <title>Research organism</title>                <kwd>Other</kwd>            </kwd-group>            <funding-group>                <award-group id="par-1">                    <funding-source><institution-wrap>                            <institution>GSK Open Lab Foundation</institution>                        </institution-wrap></funding-source>                    <award-id>TC239 and TC246</award-id>                    <principal-award-recipient><name>                            <surname>Baker</surname>                            <given-names>Stephen</given-names>                        </name></principal-award-recipient>                </award-group>                <award-group id="par-2">                    <funding-source><institution-wrap>                            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id>                            <institution>Bill and Melinda Gates Foundation</institution>                        </institution-wrap></funding-source>                    <award-id>OPP1172483</award-id>                    <principal-award-recipient><name>                            <surname>Ballell</surname>                            <given-names>Lluis</given-names>                        </name></principal-award-recipient>                </award-group>                <award-group id="par-3">                    <funding-source><institution-wrap>                            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id>                            <institution>Wellcome Trust</institution>                        </institution-wrap></funding-source>                    <award-id>215515/Z/19/Z</award-id>                    <principal-award-recipient><name>                            <surname>Baker</surname>                            <given-names>Stephen</given-names>                        </name></principal-award-recipient>                </award-group>                <funding-statement>The funders had no role in study design, data collection and                    interpretation, or the decision to submit the work for                    publication.</funding-statement>            </funding-group>        </article-meta>    </front>    <back>        <sec id="s1" sec-type="additional-information">            <title>Additional information</title>            <fn-group content-type="competing-interest">                <title>Competing interest</title>                <fn fn-type="conflict" id="conf2">                    <p>Elena Fernández Alvaro, is affiliated with GSK Global Health. The author has                        no other competing interests to declare..</p>                </fn>                <fn fn-type="conflict" id="conf3">                    <p>Cristina de Cozar, is affiliated with GSK Global Health. The author has no                        other competing interests to declare..</p>                </fn>                <fn fn-type="conflict" id="conf4">                    <p>David Wille, is affiliated with GSK Global Health. The author has no other                        competing interests to declare..</p>                </fn>                <fn fn-type="conflict" id="conf5">                    <p>Beatriz Urones, is affiliated with GSK Global Health. The author has no other                        competing interests to declare..</p>                </fn>                <fn fn-type="conflict" id="conf6">                    <p>Alvaro Cortés, is affiliated with GSK Global Health. The author has no other                        competing interests to declare..</p>                </fn>                <fn fn-type="conflict" id="conf7">                    <p>Alan Price, is affiliated with GSK Global Health. The author has no other                        competing interests to declare..</p>                </fn>                <fn fn-type="conflict" id="conf8">                    <p>Jaime de Mercado, is affiliated with GSK Global Health. The author has no                        other competing interests to declare..</p>                </fn>                <fn fn-type="conflict" id="conf9">                    <p>Pablo Castañeda, is affiliated with GSK Global Health. The author has no                        other competing interests to declare..</p>                </fn>                <fn fn-type="conflict" id="conf10">                    <p>Adolfo García-Perez, is affiliated with GSK Global Health. The author has no                        other competing interests to declare..</p>                </fn>                <fn fn-type="conflict" id="conf11">                    <p>Maria Santos Martínez-Martínez, is affiliated with GSK Global Health. The                        author has no other competing interests to declare..</p>                </fn>                <fn fn-type="conflict" id="conf12">                    <p>Lluis Ballell, is affiliated with GSK Global Health. The author has no other                        competing interests to declare..</p>                </fn>                <fn fn-type="conflict" id="conf1">                    <p>The other authors declare that no competing interests exist.</p>                </fn>            </fn-group>            <fn-group content-type="ethics-information">                <title>Ethics</title>                <fn fn-type="other">                    <p>Animal experimentation: All studies were conducted in accordance with the                        European Directive 2010/63/EEC and the GSK Policy on the Care, Welfare and                        Treatment of Laboratory Animals or were reviewed by the Institutional Animal                        Care and Use Committee at the institution where the work was performed.</p>                </fn>            </fn-group>        </sec>        <sec id="s2" sec-type="supplementary-material">            <title>Additional Files</title>            <sec id="s3" sec-type="data-availability">                <title>Data availability</title>                <p>All raw data for this project is available at 10.5281/zenodo.5929105. Exceptions                    include the propriety compound list owned by GSK. Access to compounds can be                    requested via the open lab foundation and GSK and the raw MALDI-TOF data are                    available upon request from the corresponding authors.</p>                <p>The following datasets were generated:</p>                <p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy">                        <person-group person-group-type="author"><collab>Stephen                            Baker</collab></person-group>                        <year iso-8601-date="2021">2021</year>                        <source>The repurposing of tebipenem pivoxil as alternative therapy for                            severe gastrointestinal infections caused by extensively drug resistant                            Shigella spp.</source>                        <ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/4783491#.YK_1XZNKiRY">https://zenodo.org/record/4783491#.YK_1XZNKiRY</ext-link>                        <comment>Zenodo, DOI:10.5281/zenodo.4783491</comment>                    </element-citation></p>            </sec>        <supplementary-material><ext-link xlink:href="elife-69798-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec>    </back></article>